Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Non-Muscle Invasive Bladder Neoplasms × tislelizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Recurrence 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Locally Advanced or Metastatic Urothelial Bladder Cancer 1 Locally Advanced and Metastatic Solid Tumors 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Mitomycin 8 Gemcitabine 5 apaziquone 3 Docetaxel 2 valrubicin 1 linrodostat 1 erdafitinib 1 avelumab 1 Standard of Care 1 Nivolumab 1 Neoadjuvant Therapy 1 Hyaluronic Acid 1 DDMS 1 BCG Vaccine 1 Administration, Intravesical 1 ALT-801 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡